ATAI Life Scienc
Stock
Stock
ISIN: NL0015000DX5
Ticker: ATAI
NL0015000DX5
ATAI
Price
Price
CHART BY
Frequently asked questions
What is ATAI Life Scienc's market capitalization?
The market capitalization of ATAI Life Scienc is $199.68M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for ATAI Life Scienc?
ATAI Life Scienc's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.804. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ATAI Life Scienc's stock?
Currently, 7 analysts cover ATAI Life Scienc's stock, with a consensus target price of $7.80. Analyst ratings provide insights into the stock's expected performance.
What is ATAI Life Scienc's revenue over the trailing twelve months?
Over the trailing twelve months, ATAI Life Scienc reported a revenue of $331.00K.
What is the EBITDA for ATAI Life Scienc?
ATAI Life Scienc's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$105.53M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ATAI Life Scienc?
ATAI Life Scienc has a free cash flow of -$79.86M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ATAI Life Scienc have, and what sector and industry does it belong to?
ATAI Life Scienc employs approximately 83 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of ATAI Life Scienc's shares?
The free float of ATAI Life Scienc is 117.06M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $199.68M
- EPS (TTM)
- -$0.804
- Free Float
- 117.06M
- Revenue (TTM)
- $331.00K
- EBITDA (TTM)
- -$105.53M
- Free Cashflow (TTM)
- -$79.86M
Pricing
- 1D span
- $1.196$1.235
- 52W span
- $1.03$2.845
Analyst Ratings
The price target is $7.80 and the stock is covered by 7 analysts.
Buy
7
Hold
0
Sell
0
Information
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
- Employees
- 83
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- NL0015000DX5
- Primary Ticker
- ATAI